These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11951139)

  • 21. An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease.
    Aksan A; Farrag K; Stein J
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):95-97. PubMed ID: 30791779
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
    Atherton DJ; Cox I; Hann I
    Br J Dermatol; 1999 Apr; 140(4):773. PubMed ID: 10233353
    [No Abstract]   [Full Text] [Related]  

  • 23. Anemia in inflammatory bowel diseases is much more than levels of hemoglobin.
    Bager P
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):145-6. PubMed ID: 26114170
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous iron in inflammatory bowel disease.
    Auerbach M
    Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24890797
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term management of anemia in chronic inflammatory bowel disease].
    Mickisch O; Baniewicz W; Lutz-Vorderbrügge A; Schreiber S; Küppers B
    Z Gastroenterol; 2002 Apr; 40(4):241-8. PubMed ID: 11961733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management".
    Pels LP; Van de Vijver E; Waalkens HJ; Uitentuis J; JGonera-de ong G; van Overbeek LA; Norbruis OF; Rings EH; van Rheenen PF
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):708-13. PubMed ID: 20683207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating traditional iron measures and exploring new options for patients on hemodialysis.
    Petroff S
    Nephrol Nurs J; 2005; 32(1):65-73; quiz 74-5. PubMed ID: 15787086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
    Demirtürk L; Hülagü S; Yaylaci M; Altin M; Ozel M
    Dis Colon Rectum; 1995 Aug; 38(8):896-7. PubMed ID: 7634987
    [No Abstract]   [Full Text] [Related]  

  • 31. Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Murawska N; Fabisiak A; Fichna J
    Inflamm Bowel Dis; 2016 May; 22(5):1198-208. PubMed ID: 26818422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 33. [Manifestation of iron deficiency].
    Jaeger M; Schneider W
    Med Klin (Munich); 1996 Sep; 91(9):580-8. PubMed ID: 8984317
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intravenous treatment with iron in bloodless medicine].
    Slipac J
    Cas Lek Cesk; 2009; 148(10):497-501. PubMed ID: 20662413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
    Hamada Y; Kono TN; Moriguchi Y; Higuchi M; Fukagawa M
    Nephrol Dial Transplant; 2008 Jun; 23(6):1886-91. PubMed ID: 18174266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
    Fischer MA; Morris CA; Winkelmayer WC; Avorn J
    Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
    Fishbane S; Kalantar-Zadeh K; Nissenson AR
    Semin Dial; 2004; 17(5):336-41. PubMed ID: 15461737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the optimal treatment for anemia in inflammatory bowel disease?
    Kent AJ; Blackwell VJ; Travis SP
    Curr Drug Deliv; 2012 Jul; 9(4):356-66. PubMed ID: 22023204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.